The detection of circulating tumor DNA (ctDNA) in liquid biopsy samples as an oncological
marker is being used in clinical trials at every step of clinical management. As ctDNA-based …

Ronquist G (University Hospital, Uppsala, Sweden). Prostasomes are mediators of
intercellular communication: from basic research to clinical implications (Review). J Intern …

Background The effectiveness of surgery versus observation for men with localized prostate
cancer detected by means of prostate-specific antigen (PSA) testing is not known. Methods …

BACKGROUND: Few predictive models aimed at predicting the presence of lymph node
invasion (LNI) in patients with prostate cancer (PCa) treated with extended pelvic lymph …

Background Clinical prognostic groupings for localised prostate cancers are imprecise, with
30–50% of patients recurring after image-guided radiotherapy or radical prostatectomy. We …

Importance Substantial progress has been made in cancer diagnosis and treatment,
resulting in a steady improvement in cancer survival. The degree of improvement by age …

Abstract Background The American Cancer Society, the Centers for Disease Control and
Prevention (CDC), the National Cancer Institute, and the North American Association of …

An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to
2011 - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

After 20 years of screening for breast and prostate cancer, several observations can be
made. First, the incidence of these cancers increased after the introduction of screening but …

Study Type–Prognosis (retrospective cohort) Level of Evidence 2b What's known on the
subject? and What does the study add? Upper‐tract urothelial carcinoma (UTUC) is a …